Page last updated: 2024-09-04

temiverine and Head and Neck Neoplasms

temiverine has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chou, HL; Chou, SF; Hou, PY; Hsieh, CH; Hsu, CX; Kuo, DY; Liao, LJ; Lo, WC; Shueng, PW; Wang, LY	1

Trials

1 trial(s) available for temiverine and Head and Neck Neoplasms

Article	Year
Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial. Radiation oncology (London, England), 2019, May-30, Volume: 14, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phenylacetates; Radiodermatitis; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Treatment Outcome	2019

Article

Year

Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.

Radiation oncology (London, England), 2019, May-30, Volume: 14, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phenylacetates; Radiodermatitis; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Treatment Outcome

2019